IRON - ANVISA Registration 10347320213
Access comprehensive regulatory information for IRON in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10347320213 and manufactured by HORIBA ABX SAS. The registration is held by HORIBA INSTRUMENTS BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including QUIBASA QUĂMICA BĂSICA LTDA, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
đ§đˇ Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10347320213
25351476514200960
01759236000179
Company Information
Dates and Status
Nov 30, 2009
VIGENTE
09/18/2025 19:00:01
CALCIUM
ABX PENTRA CALCIO AS CP
HORIBA ABX SAS
10347320287
May 14, 2012
CALCIUM
ABX Pentra CĂĄlcio CP
HORIBA ABX SAS
10347320253
Jun 23, 2010
INORGANIC PHOSPHORUS/PHOSPHATE
ABX PENTRA FĂSFORO CP
HORIBA ABX SAS
10347320204
Nov 16, 2009
UREA
ABX PENTRA UREIA CP
HORIBA ABX SAS
10347320207
Nov 23, 2009
ALBUMIN
ABX Pentra Albumina CP
HORIBA ABX SAS
10347320216
Nov 30, 2009
FERRO
FAMĂLIA FERRO
KATAL BIOTECNOLOGICA INDĂSTRIA E COMĂRCIO LTDA
10377390330
Sep 08, 2025
FERRO
KIT FERRO CROMAZUROL
MEDMAX COMĂRCIO DE EQUIPAMENTOS MĂDICOS E SIMILARES LTDA ME
81313770063
May 26, 2025
FERRO
FamĂlia Ferro FE Automação Linha DT
DAILYTECH LATINO AMERICA LTDA
80657030061
Jan 06, 2025
FERRO
IRON FERENE
DAILYTECH LATINO AMERICA LTDA
80657030033
Dec 23, 2024
FERRO
FAMĂLIA FERRO CROMAZUROL MONORREAGENTE
QUIBASA QUĂMICA BĂSICA LTDA
10269360451
May 13, 2024